Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Diffuse Optical Spectroscopy and Tomography for Monitoring Chemotherapy Efficacy in Locally Advanced Breast Cancer

Not Accessible

Your library or personal account may give you access

Abstract

Tomographic diffuse optical spectroscopy parameters of Hb, HbO2, %water and scattering power can be used as an early detector of final pathologic tumour response in women treated with neoadjuvant therapy for locally advanced breast cancer.

© 2010 Optical Society of America

PDF Article
More Like This
Breast Cancer Therapy Monitoring with Diffuse Optical Tomography and Diffuse Correlation Spectroscopy

Regine Choe, Turgut Durduran, So Hyun Chung, Soren D. Konecky, Saurav Pathak, Han Y. Ban, David R. Busch, Erin M. Buckley, Meeri N. Kim, Angela DeMichele, Carolyn Mies, Mark A. Rosen, Mitchell D. Schnall, and Arjun G. Yodh
BSuB2 Biomedical Optics (BIOMED) 2010

Monitoring Breast Cancer Tumor Response At Different Timepoints During Pre-Surgical Chemotherapy with Diffuse Optical Spectroscopic Imaging

Albert E. Cerussi, Vaya W. Tanamai, Darren Roblyer, Shigeto Ueda, Amanda F. Durkin, Rita S. Mehta, David Hsiang, John Butler, and Bruce J. Tromberg
FME1 Frontiers in Optics (FiO) 2010

Multispectral and phase-contrast diffuse optical tomography of breast cancer during neoadjuvant chemotherapy

Xiaoping Liang, Qizhi Zhang, Stephen Staal, Stephen Grobmyer, and Huabei Jiang
JMA81 Biomedical Optics (BIOMED) 2010

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved